AMYLIN PHARMACEUTICALS INC (AMLN) has 51 open-market insider trades by 15 insiders since 2007. The most active filer is Capital Management Llc/ca Eastbourne, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Capital Management Llc/ca Eastbourne | 10% | — | 15 | $269.2M | 2009-09-17 |
| Bear Offshore Master Fund Lp Black | 10% | — | 11 | $166.0M | 2008-08-27 |
| Thomas R. Testman | Dir | — | 2 | $1.5M | 2007-06-01 |
| Marcea Bland Lloyd | SVPChief Administrative Offi | — | 2 | $254K | 2012-08-08 |
| Orville G. Kolterman | SVPChief Medical Officer | — | 3 | $221K | 2012-08-08 |
| Vincent P. Mihalik | SVPChief Commercial Officer | — | 3 | $213K | 2012-08-08 |
| Mark J. Gergen | SVPCorporate Development | — | 2 | $160K | 2012-08-08 |
| Christian Weyer | SVPResearch & Development | — | 4 | $145K | 2012-08-08 |
| Mark G. Foletta | CFOSVP | — | 2 | $128K | 2012-08-08 |
| Paul Marshall | SVPOperations | — | 1 | $96K | 2012-08-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Lloyd A. Rowland | VP & Chief Compliance Officer | Sell | $189K | 2012-03-28 |
| Mark G. Foletta | CFO & SVP | Sell | $32K | 2012-03-01 |
| Harry J. Leonhardt | SVP & Legal +1 | Sell | $21K | 2012-03-01 |
| Daniel Bradbury | President | Sell | $26K | 2012-03-01 |
| Mark J. Gergen | SVP & Corporate Development | Sell | $128K | 2012-02-23 |
| Christian Weyer | SVP & Research & Development | Sell | $43K |
Companies that share insiders with AMLN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2012-02-23 |
| Paul Marshall | SVP & Operations | Sell | $96K | 2012-02-23 |
| Harry J. Leonhardt | SVP & Legal +1 | Sell | $37K | 2012-02-23 |
| Christian Weyer | SVP & Research & Development | Sell | $64K | 2012-02-08 |
| Marcea Bland Lloyd | SVP & Chief Administrative Offi | Sell | $222K | 2012-02-08 |
| Vincent P. Mihalik | SVP & Chief Commercial Officer | Sell | $64K | 2012-02-08 |
| Orville G. Kolterman | SVP & Chief Medical Officer | Sell | $94K | 2012-02-08 |
| Alexander J. Denner | Director | Sell | $21K | 2012-01-17 |
| Orville G. Kolterman | SVP & Chief Medical Officer | Sell | $131K | 2011-10-03 |
| Orville G. Kolterman | SVP & Chief Medical Officer | Sell | $207K | 2011-03-01 |